Brief: G1 Therapeutics Provides First Quarter 2023 Financial Results And Operational Highlights
03/05/2023 12:26
G1 Therapeutics Inc GTHX.O :
* G1 THERAPEUTICS PROVIDES FIRST QUARTER 2023 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* G1 THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.53
* G1 THERAPEUTICS INC - G1 TODAY REITERATED ITS FULL YEAR
2023 NET
REVENUE GUIDANCE
* G1 THERAPEUTICS INC - EXPECTS TO GENERATE BETWEEN $50
MILLION
AND $60 MILLION IN COSELA NET REVENUE IN 2023
Source text for Eikon: ID:nGNX2KpVcM
Further company coverage: GTHX.O
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify